2017 Opioid Abuse and the PDMP Webinar Posttest
Please answer the following questions to receive CME credit. Thank you!
As of January 1, 2017, who must report in the PDMP?
A. Prescription dispenser
B. Prescription dispenser designee
C. Wholesale distributor of a monitored prescription drug
D. Licensed veterinarian
E. Both A and B
What could you do if you find or suspect prescription misuse, fraud, and/or forgery?
A. Review the substance misuse quick reference guide.
B. Prepare a patient pain management agreement.
C. The PDMP routinely monitors dispensed drugs - no action needed.
D. Contact the prescriber, verify the consumer's identity, and/or contact the local police.
E. Both A, B and D.
What are important changes implemented with LB223?
A. Allows a prescriber to authorize a designee.
B. Requires mandatory training on the PDMP.
C. The law takes effect when approved by the Governor.
D. Requires physicians to report all written prescriptions.
E. A, B, and C.
In acute pain situations, if writing for an opiate the CDC recommends, it be written for a _____ day supply.
Which of the following medications can be prescribed for substance abuse in an office setting and without an X on your DEA number?
B. Buprenorphine subdermal implant
C. Naltrexone injection
D. Naloxone injection
E. Both C and D
Do Not Fill This Out